News about product and service launches
ZEISS Elyra 7 with Lattice SIM expands the possibilities of structured illumination microscopy (SIM) News ZEISS Elyra 7 with Lattice SIM is a new flexible platform for fast and gentle 3D superresolution. Lattice SIM expands the possibilities of structured illumination microscopy (SIM): illuminating the sample with a lattice pattern rather than grid lines gives higher... Read more
MINNEAPOLIS, Dec. 4, 2018 /PRNewswire/ — Bio-Techne has further added to its cell therapy portfolio by expanding the range of Tocris Bioscience-branded cGMP small molecules to include the commonly used stem cell compounds, Y-27632 (ROCK inhibitor) and CHIR 99021. Y-27632 is a ROCK inhibitor used in stem cell cryopreservation, expansion and differentiation protocols to enhance stem cell survival... Read more
A new platform for fast and gentle 3D superresolution microscopy JENA/Germany, 2018-12-04. ZEISS is introducing ZEISS Elyra 7 with Lattice SIM, a new flexible platform for fast and gentle 3D superresolution. Lattice SIM expands the possibilities of structured illumination microscopy (SIM): illuminating the sample with a lattice pattern rather than grid lines gives higher contrast... Read more
Basel, 04 December 2018 New Venclexta/Venclyxto data demonstrate deep responses in two of the most common types of leukaemia New analyses from the phase III MURANO study in previously treated chronic lymphocytic leukaemia show continued benefit from fixed-duration regimen after a median follow-up of three years Updated results from two studies in newly-diagnosed acute myeloid... Read more
Brooks Automation Announces Participation in the Seventh Annual New York City Investor Summit CHELMSFORD, Mass., Dec. 3, 2018 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that Steve Schwartz, President and Chief Executive Officer, and Lindon Robertson, Executive Vice President and Chief Financial Officer, will participate in the 7th Annual New York City Investor Summit... Read more
Including a first-of-its-kind ultra-micro balance, the METTLER TOLEDO’s XPR line presents a welcome combination of usability and accuracy. This combination is critical in industries such as pharmaceuticals where sample sizes are small and productivity must be maintained. Greifensee, Switzerland—December 2, 2018—Notable in this line is XPR6UD5, the first ultra-micro balance on the market. It offers a... Read more
Hilden, Germany, Germantown, Maryland, Fort Myers, Florida, November 30, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeoGenomics, Inc. (NASDAQ: NEO) today announced a master service agreement to accelerate the availability of innovative companion diagnostics that enable precision medicine for cancer patients. The partnership between QIAGEN and NeoGenomics, a leading provider of... Read more
SHANGHAI, Nov. 30, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today opened its first Bioprocess Design Center in Shanghai, China. The new center is part of a strategy to establish a center of excellence where Thermo Fisher scientists can connect and collaborate with biologic developers to design optimal bioprocessing solutions. The 2,700-square-meter... Read more
Hilden, Germany, and Germantown, Maryland, November 29, 2018 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two novel products to deliver actionable insights on a wide range of blood cancers: a new workflow for the QIAGEN Clinical Insight (QCI) Interpret bioinformatics solution for hematological malignancies, and the new QIAact Myeloid... Read more
(ANN ARBOR, Mich. – November 28, 2018) Swift Biosciences today announced the availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation. Compared to conventional normalization, Swift Normalase saves cost on sequencing by reducing read depth variation within a pool down to... Read more